Clicky

Elanco Animal Health Incorporated(5EA)

Description: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.


Keywords: Pain Antibiotics Livestock Osteoarthritis Meat Industry Probiotic Vaccine Products Veterinarian Veterinary Medicine In The United States Ear Infections Imidacloprid/Permethrin/Pyriproxyfen Nutritional Health Products

Home Page: www.elanco.com

2500 Innovation Way
Greenfield, IN 46140
United States
Phone: 877 352 6261


Officers

Name Title
Mr. Jeffrey N. Simmons President, CEO & Director
Mr. Todd S. Young J.D. Executive VP & CFO
Dr. Ramiro Martin Cabral Executive Vice President of Elanco International
Dr. Ellen de Brabander Ph.D. Executive Vice President of Research, Development & Regulatory Affairs
Mr. Timothy J. Bettington Executive Vice President of Corporate Strategy & Market Development
Mr. James M. Meer Senior VP & Chief Accounting Officer
Mr. Chris Keeley Senior VP & Chief Information Officer
Mr. David S. Kinard Executive Vice President of Human Resources, Corporate Communications & Administration
Ms. Katy Grissom Head of Investor Relations
Ms. Shiv O'Neill Executive Vice President, General Counsel & Corporate Secretary

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 12.3457
Trailing PE: 29.1538
Price-to-Book MRQ: 0.9121
Price-to-Sales TTM: 1.2797
IPO Date:
Fiscal Year End: December
Full Time Employees: 9300
Back to stocks